BRO vs STOK · P/E 30, rev $3.58B vs rev $15.6M
Brown & Brown Inc (BRO) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2026-06-30 was $3.58B. Net income was $714.0M. Revenue was up 88.2% from 2026-03-31 to 2026-06-30. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. STOK currently screens at market cap $1.88B.
Not investment advice. Open the BRO and STOK stock pages for the full models.
Not investment advice.